At PassionBio.tech, we don’t just advise companies – we build them.
We support NewCos beyond capital raising by stepping in operationally, assembling leadership teams, and guiding early strategic decisions. Our venture-building model includes interim management, business development, scientific positioning, and investor readiness from day one. Here’s a closer look at one of our recent projects, which exemplifies our venture-building approach from inception to early validation.
Company: NewCo
Mission: To transform metabolic disease management through a novel class of engineered postbiotics, enabling durable glycemic control via the gut-liver axis.
Stage: Seed
Industry: Microbiome Therapeutics
Market: $10–15B addressable market across type 2 diabetes, NAFLD, and obesity-linked metabolic dysfunction.
Deployment: Seed round to complete in vivo PoC, scale bioprocess to GMP-like quality, and prepare for first partnering discussions.
Email us at agile.advisor@passionbio.tech if:
· You’re interested in venture co-creation or seed-stage co-investment
· You’re exploring a collaboration on a biotech venture building
· You’re building or backing early-stage biotech
· You’re engaged in co-developing next-generation biotech companies